Cushing's disease is one of the most fascinating disorders in the whole of
endocrinology, in which a minute tumour in the pituitary gives rise to a wh
ole panoply of symptoms, signs and changes in mood and behaviour. Recent re
search has begun to identify the molecular changes in these tumours underly
ing the reduced sensitivity of the tumour cells to normal feedback regulati
on and cell cycle control, which may eventually lead to specific gene thera
py.